Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
Studer Jacqueline
  2. Issuer Name and Ticker or Trading Symbol
IDEXX LABORATORIES INC /DE [IDXX]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
CVP, Gen. Counsel & Secretary
(Last)
(First)
(Middle)
ONE IDEXX DRIVE
3. Date of Earliest Transaction (Month/Day/Year)
02/14/2018
(Street)

WESTBROOK, ME 04092
4. If Amendment, Date Original Filed(Month/Day/Year)
6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/14/2018   M   346 A $ 0 4,757 (1) D  
Common Stock 02/14/2018   M   406 A $ 0 5,163 D  
Common Stock 02/14/2018   M   212 A $ 0 5,375 D  
Common Stock 02/14/2018   F   298 D $ 178.26 (2) 5,077 D  

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(Month/Day/Year)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Option (right-to-buy) $ 178.26 02/14/2018   A   8,007     (3) 02/13/2028 Common Stock 8,007 (9) 8,007 D  
Incentive Stock Option (right-to-buy) $ 178.26 02/14/2018   A   560     (4) 02/13/2028 Common Stock 560 (9) 560 D  
Restricted Stock Unit (5) 02/14/2018   A   841     (5)   (5) Common Stock 841 (9) 6,815 D  
Restricted Stock Unit (6) 02/14/2018   M     346   (6)   (6) Common Stock 346 (9) 6,469 D  
Restricted Stock Unit (7) 02/14/2018   M     406   (7)   (7) Common Stock 406 (9) 6,063 D  
Restricted Stock Unit (8) 02/14/2018   M     212   (8)   (8) Common Stock 212 (9) 5,851 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
Studer Jacqueline
ONE IDEXX DRIVE
WESTBROOK, ME 04092
      CVP, Gen. Counsel & Secretary  

Signatures

 /s/ Lily J. Lu, Attorney-in-Fact for Jacqueline L. Studer   02/16/2018
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Includes a total of 72 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on September 29, 2017 and December 29, 2017.
(2) Closing price of Issuer's common stock on the NASDAQ market on February 14, 2018.
(3) Grant of option to buy shares of Issuer common stock that becomes exercisable in five annual installments beginning February 14, 2019.
(4) Grant of option to buy shares of Issuer common stock that becomes exercisable on the fifth anniversary of the date of grant.
(5) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2019.
(6) Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2016. The number of RSUs have been adjusted to reflect the 2-for-1 stock split of Issuer common stock that occurred on June 15, 2015.
(7) Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2017.
(8) Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2018.
(9) Not applicable.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.